Past Highlights

Welcome to the Past Highlights page, our collection of featured publications, research, and news.

np_Two chemist working in pharmacy drugstore_5qDmK0_free.jpg

Population-level impact of initiating pharmacotherapy and linking to care persons with opioid use disorder at inpatient medically managed withdrawal programs: an effectiveness and cost effectiveness analysis

Savinkina A, Madushani RWMA, Yazdi GE, Wang J, Barocas JA, Morgan JR, Assoumou SA, Walley AY, Linas BP, Murphy SM

Modeling the cost-effectiveness and impact on fatal overdose and initiation of buprenorphine-naloxone treatment at syringe service programs

Adams JW, Savinkina A, Fox A, Behrands CN, Madushani RWMA, Wang J, Chatterjee A, Walley AY, Barocas JA, Linas BP

np_Close up of COVID-19 vaccine syringes_bxGyM4_full.jpg

np_Woman doctor in staff meeting at hospital_0yzvW5_free_edited.jpg

Determining the lower limit of detection required for HCV viral load assay for test of cure following direct-acting antiviral based treatment regimens: evidence from a global dataset

Morgan JR, Marsh E, Savinkina A, Shilton S, Shadaker S, Tsertsvadze T, Kamkamidze G, Alkhazashvili M, et al.

Recent Addiction Journal Publications

On March 21, 2022, Addiction Journal published two publications, one led by Dr. Joëlla Adams and the other led by Alexandra Savinkina, both alumni of the Syndemics Team. The publication by Adams found that offering buprenorphine treatment on-site within syringe services programs could substantially decrease drug overdoses, improve treatment engagement, and save on costs. Savinkina’s publication found that linking detox patients to outpatient care and initiating MOUD while in detox could prevent fatal overdoses among people with OUD and would be cost-effective from a healthcare sector perspective.

np_Needle and disinfectant pad on blue background_5w67W0_free_edited.jpg

2022 Penn LDI/CHERISH Virtual Conference

On January 14th, Mathieu Castry and Ben Linas presented preliminary results on the projected impact of implementing state licensure standards to improve access to medications for opioid use disorder (MOUD) in residential treatment at the Penn LDI/CHERISH Virtual Conference. The conference explored how states can use licensing authorities to address gaps in access to MOUDs in treatment facilities through modeling. Learn more about Mathieu and Ben’s research and about the conference below.